TY - JOUR
T1 - The Promise of Telemedicine for Movement Disorders
T2 - an Interdisciplinary Approach
AU - the International Parkinson and Movement Disorder Society Telemedicine Task Force
AU - Ben-Pazi, H.
AU - Browne, P.
AU - Chan, P.
AU - Cubo, E.
AU - Guttman, M.
AU - Hassan, A.
AU - Hatcher-Martin, J.
AU - Mari, Z.
AU - Moukheiber, E.
AU - Okubadejo, N. U.
AU - Shalash, A.
AU - Bajwa, J.
AU - Bloem, B. R.
AU - Galifianakis, N. B.
AU - Gatto, E.
AU - Goetz, C. G.
AU - Katz, M.
AU - Pantelyat, A.
AU - Tanner, C.
AU - Spindler, M.
N1 - Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Purpose of Review: Advances in technology have expanded telemedicine opportunities covering medical practice, research, and education. This is of particular importance in movement disorders (MDs), where the combination of disease progression, mobility limitations, and the sparse distribution of MD specialists increase the difficulty to access. In this review, we discuss the prospects, challenges, and strategies for telemedicine in MDs. Recent Findings: Telemedicine for MDs has been mainly evaluated in Parkinson’s disease (PD) and compared to in-office care is cost-effective with similar clinical care, despite the barriers to engagement. However, particular groups including pediatric patients, rare MDs, and the use of telemedicine in underserved areas need further research. Summary: Interdisciplinary telemedicine and tele-education for MDs are feasible, provide similar care, and reduce travel costs and travel time compared to in-person visits. These benefits have been mainly demonstrated for PD but serve as a model for further validation in other movement disorders.
AB - Purpose of Review: Advances in technology have expanded telemedicine opportunities covering medical practice, research, and education. This is of particular importance in movement disorders (MDs), where the combination of disease progression, mobility limitations, and the sparse distribution of MD specialists increase the difficulty to access. In this review, we discuss the prospects, challenges, and strategies for telemedicine in MDs. Recent Findings: Telemedicine for MDs has been mainly evaluated in Parkinson’s disease (PD) and compared to in-office care is cost-effective with similar clinical care, despite the barriers to engagement. However, particular groups including pediatric patients, rare MDs, and the use of telemedicine in underserved areas need further research. Summary: Interdisciplinary telemedicine and tele-education for MDs are feasible, provide similar care, and reduce travel costs and travel time compared to in-person visits. These benefits have been mainly demonstrated for PD but serve as a model for further validation in other movement disorders.
KW - Movement disorders
KW - Tele-education
KW - Telehealth
KW - Telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85045405819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045405819&partnerID=8YFLogxK
U2 - 10.1007/s11910-018-0834-6
DO - 10.1007/s11910-018-0834-6
M3 - Review article
C2 - 29654523
AN - SCOPUS:85045405819
SN - 1528-4042
VL - 18
JO - Current neurology and neuroscience reports
JF - Current neurology and neuroscience reports
IS - 5
M1 - 26
ER -